Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUEST for smoking cessation in homeless youth with ABI
NCT06745154Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jun 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of nicotine in Tobacco Use Disorder (TUD), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: Rate of executive function difficulties at 8 weeks and Factors impacting access to evidence-based treatment at 8 weeks. Started Jun 2023; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT06745154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06745154.